Dabotulinumtoixna-ianm-(DAXXIFY)- (Sep 2022)- to treat moderate to severe glabellar lines associated with corrugation

Drug Name:
Dabotulinumtoixna-ianm-(DAXXIFY)- (Sep 2022)- to treat moderate to severe glabellar lines associated with corrugation

List Of Brands:

Indication Type Description:

Indication